Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. North America Research Institute

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

North America Research Institute (NARI) is a physician-owned and operated Site Management Organization (SMO) based in San Dimas, California, with an associated network of clinical research sites across Southern California. The institute conducts Phase I–IV clinical trials for pharmaceutical, biotechnology, and medical device companies, supported by board-certified physician investigators and experienced research coordinators. Its clinical research capabilities include patient screening and recruitment, study start-up, regulatory and contract management, clinical data collection, and quality assurance. NARI has experience across several therapeutic areas, including nephrology, diabetes, endocrinology, cardiovascular conditions, and infectious diseases. Its facilities support clinical trial activities through dedicated research spaces, investigational product storage, and diagnostic services.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Trial-derived.
29Total Trials
Source: Trial-derived.
7Recruiting Trials
Source: Trial-derived.
15Active Trials
Source: Trial-derived.
11Completed Trials
Source: Trial-derived.
49Unique Conditions
Source: Trial-derived.
21Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Chronic Kidney Disease (5)Source: Trial-derived. Diabetic Kidney Disease (3)Source: Trial-derived. Chronic Kidney Diseases (2)Source: Trial-derived. Diabetes Mellitus, Type 2 (2)Source: Trial-derived. End Stage Kidney Disease (2)Source: Trial-derived. Focal Segmental Glomerulosclerosis (2)Source: Trial-derived. Heart Failure (2)Source: Trial-derived. IgA Nephropathy (2)

Sponsors

Source: Trial-derived. Novo Nordisk A/S (8)Source: Trial-derived. Boehringer Ingelheim (3)Source: Trial-derived. Novartis Pharmaceuticals (3)Source: Trial-derived. CSL Behring (2)Source: Trial-derived. Akebia Therapeutics (1)Source: Trial-derived. Alebund Pharmaceuticals (1)Source: Trial-derived. Cerium Pharmaceuticals, Inc. (1)Source: Trial-derived. Cyclerion Therapeutics (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Dialysis
Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Automated office blood pressure (AOBP) measurement
Source: AI-inferred. Participant mobile study app (eDiary/ePRO)